Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ralph Gambardella

Sports Medicine Los Angeles, CA Medical Doctor

NPI 1205803087 CMS profile 909718

6801 Park Ter, Los Angeles, CA 90045

Open in the dashboard

General payments

$30,575

96 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,340 paid to institutions, not to them · program years 2020–2021

Through program year 2025, Ralph Gambardella of Los Angeles, CA is reported in the CMS Open Payments database as having received $30,575 across 96 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $2,340 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 76th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,477 20
2024 General $1,169 11
2023 General $1,085 9
2022 General $1,472 6
2021 General $1,130 10
2020 General $6,992 8
2019 General $17,250 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ralph Gambardella
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Ralph Gambardella were reported at $1,477. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Ralph Gambardella Sports Medicine median Middle half National median
2019 $17,250 $1,176 $199–$4,249 $163
2020 $6,992 $708 $96–$2,890 $114
2021 $1,130 $1,213 $152–$3,994 $132
2022 $1,472 $1,230 $159–$3,998 $149
2023 $1,085 $584 $146–$2,836 $160
2024 $1,169 $628 $163–$3,168 $164
2025 $1,477 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $22,633 49 payments
  2. Stryker Corporation $3,062 30 payments
  3. Medical Device Business Services, Inc. $2,633 1 payment
  4. Arcuro Medical Inc $1,173 4 payments
  5. Zimmer Biomet Holdings, Inc. $186 2 payments
  6. Miach Orthopaedics, Inc. $183 1 payment
  7. Vericel Corporation $171 3 payments
  8. Saxum Surgical, Inc. $150 1 payment
  9. Bioventus LLC $149 2 payments
  10. Aesculap Biologics, LLC $126 1 payment
  11. Other $108 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,806 7 payments
  2. Food and Beverage $8,083 87 payments
  3. Consulting Fee $2,633 1 payment
  4. Travel and Lodging $53 1 payment
Products named General payments · program years 2019–2025
  1. Coblation Wands $15,080 6 payments
  2. 560 SERIES HD Camera System $3,806 1 payment
  3. COR $2,633 1 payment
  4. Topaz $2,500 1 payment
  5. Covac $2,500 1 payment
  6. Microblator 30 $2,500 1 payment
  7. CINCHLOCK SS $1,717 20 payments
  8. SUPERBALL $1,173 4 payments
  9. CINCHLOCK $889 7 payments
  10. N/A $801 9 payments
  11. Other $5,017 56 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

67

Median for Sports Medicine: 144

Drug cost

$608

Median for Sports Medicine: $1,027

Branded share of claims

55.2%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Er Diclofenac Sodium Brand 37 $426
Celecoxib Generic 16 $160
Meloxicam Generic 14 $23

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$70,988

Of which drugs: $4,523

Medicare patients

294

Average age 72

Services billed

796

143 women, 151 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 74%
High blood pressure 57%
Ischemic heart disease 30%
Diabetes 19%
Osteoporosis 19%
Cancer 13%
Chronic kidney disease 12%
Depression 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 14 29 $137

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

96 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record